Radiopharm Theranostics Limited
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -75.9% | -75.9% | — |
| FY2024 | -175.3% | -175.3% | -66.6% |
| FY2025 | -89.4% | -89.4% | -44.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -75.9% | -75.9% | — |
| FY2024 | -175.3% | -175.3% | -66.6% |
| FY2025 | -89.4% | -89.4% | -44.3% |